Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
暂无分享,去创建一个
J Weissenburger | J. Davy | J. Poirier | J M Poirier | J M Davy | J. Weissenburger | F Chézalviel-Guilbert | F. Chézalviel-Guilbert
[1] E. Aliot,et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. , 1988, Progress in cardiovascular diseases.
[2] U. Borchard,et al. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects. , 1988, Arzneimittel-Forschung.
[3] E. Carmeliet. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. , 1985, The Journal of pharmacology and experimental therapeutics.
[4] K. Nademanee,et al. Sotalol , 1987, Drugs.
[5] J. Davy,et al. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. , 1991, The Journal of pharmacology and experimental therapeutics.
[6] A. Shah,et al. Mexiletine for treatment of torsade de pointes. , 1984, American heart journal.
[7] A. Kadish,et al. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate. , 1991, American heart journal.
[8] J. Davy,et al. Methods and limitations of an experimental model of long QT syndrome. , 1991, Journal of pharmacological methods.
[9] C. January,et al. A Model for Early Afterdepolarizations: Induction With the Ca2+ Channel Agonist Bay K 8644 , 1988, Circulation research.
[10] G. Kay,et al. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. , 1983, Journal of the American College of Cardiology.
[11] M. Arita,et al. Comparison of the inhibitory effects of mexiletine and lidocaine on the calcium current of single ventricular cells. , 1986, Life sciences.
[12] M. Arita,et al. ELECTROPHYSIOLOGICAL ACTIONS OF MEXILETINE (Kö1173) ON CANINE PURKINJE FIBRES AND VENTRICULAR MUSCLE , 1979, British journal of pharmacology.
[13] M R Franz,et al. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. , 1989, The Journal of pharmacology and experimental therapeutics.
[14] K. Nademanee,et al. Sotalol: a beta blocker with unique antiarrhythmic properties. , 1987, American heart journal.
[15] J. Brachmann,et al. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle. , 1991, The American journal of cardiology.
[16] A. Keren,et al. Etiology, Warning Signs and Therapy of Torsade de Pointes: A Study of 10 Patients , 1981, Circulation.
[17] D. Wyse,et al. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans. , 1987, Journal of the American College of Cardiology.
[18] A. Varró,et al. Sotalol and Mexiletine: Combination of Rate‐Dependent Electrophysiological Effects , 1990, Journal of cardiovascular pharmacology.
[19] N. Akaike,et al. Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide. , 1985, Journal of molecular and cellular cardiology.
[20] J. Barlow,et al. Sotalol, hypokalaemia, syncope, and torsade de pointes. , 1984, British heart journal.
[21] B. Surawicz,et al. Effect of Antiarrhythmic Drugs on the Cycle Length-Dependent Action Potential Duration in Dog Purkinje and Ventricular Muscle Fibers , 1986, Journal of cardiovascular pharmacology.
[22] A. Mallet,et al. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. , 1991, Circulation.
[23] B. Strasberg,et al. Polymorphous ventricular tachycardia: clinical features and treatment. , 1979, The American journal of cardiology.
[24] W Craelius,et al. QTU Prolongation and Polymorphic Ventricular Tachyarrhythmias Due to Bradycardia‐Dependent Early: Afterdepolarizations Afterdepolarizations and Ventricular Arrhythmias , 1988, Circulation research.
[25] D. Roden,et al. Mexiletine in the Treatment of Resistant Ventricular Arrhythmias: Enhancement of Efficacy and Reduction of Dose‐related Side Effects by Combination with Quinidine , 1983, Circulation.
[26] S. Hering,et al. Sodium current in freshly isolated and in cultured single rat myocardial cells: frequency and voltage-dependent block by mexiletine. , 1983, Journal of molecular and cellular cardiology.
[27] S. Nattel,et al. Concentration dependence of class III and beta-adrenergic blocking effects of sotalol in anesthetized dogs. , 1989, Journal of the American College of Cardiology.
[28] B. Singh,et al. A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 , 1970, British journal of pharmacology.
[29] J. Bigger,et al. Electrophysiological and Beta‐Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue , 1970, Circulation research.
[30] A. Uprichard,et al. Atenolol, but not mexiletine, protects against stimulus‐induced ventricular tachycardia in a chronic canine model , 1989, British journal of pharmacology.
[31] B. Lüderitz,et al. Combination of Antiarrhythmic Drugs , 1991, Journal of cardiovascular pharmacology.
[32] A. Varró,et al. The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate‐dependent , 1990, British journal of pharmacology.
[33] G. Cheymol,et al. Rapid and sensitive column liquid chromatographic determination of sotalol in plasma. , 1989, Journal of chromatography.